Skip to content

DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients

Clinical Performance of the DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07290608
Acronym
DOACT
Enrollment
59
Registered
2025-12-18
Start date
2025-01-20
Completion date
2025-10-10
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Clinical Decision Support Systems, Deep Vein Thrombosis, Pulmonary Thromboembolisms, Superficial Thrombophlebitis

Keywords

anticoagulant, algorithm, thrombosis

Brief summary

Study using a decision algorithm for the application of an oral anticoagulant calculator in vascular diseases, aimed at validating a clinical decision-support tool for conditions such as deep vein thrombosis, superficial thrombophlebitis, and pulmonary thromboembolism.

Detailed description

Cross-sectional, three-arm comparative validation study evaluating the accuracy and clinical utility of the DOACT algorithm versus standard clinical decision-making and large language model (LLM)-based decision tools.

Interventions

OTHERDOACT algorithm

Vascular and non-vascular physicians using DOACT (Dose-Oriented Anticoagulant Calculator for Evidence-Based Decision Tool) to recommend appropriate oral anticoagulant regimens-dose selection and duration responding 15 standardized clinical case vignettes representing patients with vascular diseases such as deep vein thrombosis (DVT), superficial thrombophlebitis, and pulmonary thromboembolism (PTE).

OTHERNo algorithm

Vascular and non-vascular physicians using standard clinical decision-making (no use of algorithm) to recommend appropriate oral anticoagulant regimens-dose selection and duration responding 15 standardized clinical case vignettes representing patients with vascular diseases such as deep vein thrombosis (DVT), superficial thrombophlebitis, and pulmonary thromboembolism (PTE).

OTHERLLM-based tools

Vascular and non-vascular physicians using large language model (LLM)-based tools to recommend appropriate oral anticoagulant regimens-dose selection and duration responding 15 standardized clinical case vignettes representing patients with vascular diseases such as deep vein thrombosis (DVT), superficial thrombophlebitis, and pulmonary thromboembolism (PTE).

Sponsors

ITALO EUGENIO SOUZA GADELHA DE ABREU
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Masking description

Single-blind. Investigator was blinded to the intervention assignment.

Intervention model description

Three-arm comparative validation study evaluating the accuracy and clinical utility of the DOACT algorithm versus standard clinical decision-making and large language model (LLM)-based decision tools.

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Physicians with residency training in Vascular Surgery or official Board Certification in Vascular Surgery. * Currently practicing clinical and/or surgical vascular care in Brazil. * Completed the informed consent process (TCLE) and voluntarily agreed to participate.

Exclusion criteria

* Physicians without formal Vascular Surgery residency and without Board Certification. * Physicians not performing vascular clinical or surgical care (e.g., exclusively administrative, academic, or non-assistance roles). * Less than 1 year of professional experience after medical school graduation. * Did not sign or did not fully complete the TCLE. Large Language Models (LLMs) * Inclusion Criteria * Free-access LLMs available to the public at the time of data collection. * All responses generated using the same standardized prompt. * Capable of producing complete, text-based clinical answers relevant to vascular surgery decision-making.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of the DOACT Algorithm in Guiding Oral Anticoagulant TherapyDay 1Accuracy of anticoagulation recommendations Description: Proportion of correct responses generated by the four evaluated LLMs, vascular surgeons, and non-vascular physicians, with and without access to the DOACT algorithm, using standardized clinical vignettes.
Accuracy of anticoagulation recommendationsDay 1Proportion of correct responses generated by LLMs, vascular surgeons, and non-vascular physicians with and without access to the DOACT algorithm. All LLM outputs will be generated using the same standardized prompt, following methodological guidance recommended by IBM for evaluating large language models.

Other

MeasureTime frameDescription
1. Identification of key clinical elements 2.Response timeDay 1Correct reporting of dosing adjustments, renal criteria, bleeding risks, reversal agents, and contraindications. Description: Time (seconds) from prompt submission to full answer generation for LLMs, and time to completion for physicians.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026